Link Pharmaceutical

Link Pharmaceuticals, a division of Link Healthcare and now a subsidiary of the Clinigen Group, is a specialty pharmaceutical company focused on the Asia-Pacific and Southern Africa regions. The company specializes in the acquisition, licensing, and commercialization of specialist medicines, including orphan drugs and emergency therapies. Link provides a comprehensive suite of services including regulatory affairs, medical information, and a robust distribution network to help global pharmaceutical partners enter complex regional markets. Its core business units include Commercial Medicines, Managed Access for unlicensed products, and Medical Technology. Following its acquisition by Clinigen in 2015, Link has become a key component of a global platform dedicated to improving patient access to critical medicines.